SevenBridge Financial Group LLC Cuts Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

SevenBridge Financial Group LLC trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 12.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,734 shares of the financial services provider’s stock after selling 400 shares during the period. SevenBridge Financial Group LLC’s holdings in iShares Biotechnology ETF were worth $367,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the company. Huntington National Bank increased its position in iShares Biotechnology ETF by 21.4% during the 4th quarter. Huntington National Bank now owns 1,280 shares of the financial services provider’s stock worth $169,000 after purchasing an additional 226 shares during the period. Nemes Rush Group LLC grew its holdings in iShares Biotechnology ETF by 1,464.5% during the fourth quarter. Nemes Rush Group LLC now owns 6,430 shares of the financial services provider’s stock worth $850,000 after acquiring an additional 6,019 shares during the period. Hoey Investments Inc. acquired a new position in iShares Biotechnology ETF during the fourth quarter worth $70,000. Edmond DE Rothschild Holding S.A. raised its position in iShares Biotechnology ETF by 636.3% in the fourth quarter. Edmond DE Rothschild Holding S.A. now owns 5,890 shares of the financial services provider’s stock worth $779,000 after acquiring an additional 5,090 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC lifted its holdings in iShares Biotechnology ETF by 10.8% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 2,745 shares of the financial services provider’s stock valued at $363,000 after acquiring an additional 267 shares during the period. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 1.9 %

NASDAQ:IBB opened at $126.79 on Thursday. The firm’s fifty day simple moving average is $135.64 and its 200-day simple moving average is $138.50. The stock has a market cap of $5.99 billion, a PE ratio of 27.83 and a beta of 0.84. iShares Biotechnology ETF has a fifty-two week low of $123.21 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Increases Dividend

The business also recently announced a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were given a dividend of $0.1212 per share. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date was Tuesday, March 18th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.